Literature DB >> 6466615

Inhibition of bovine heart NAD-specific isocitrate dehydrogenase by reduced pyridine nucleotides: modulation of inhibition by ADP, NAD+, Ca2+, citrate, and isocitrate.

J L Gabriel, G W Plaut.   

Abstract

The activity of NAD-dependent isocitrate dehydrogenase from bovine heart was inhibited by NADH (apparent Ki about 4.3 microM) and NADPH (Ki about 9.8 microM) at subsaturating substrate concentrations at pH 7.4. The inhibition by NADH or NADPH was reversed competitively by magnesium isocitrate in the presence of ADP, but not without ADP. Reversal of inhibition by NADH or NADPH with respect to NAD+ was competitive or of the linear mixed type depending on whether ADP was absent or present. ADP3- (0.2 mM) increased the Ki(app) for NADPH from 9.8 to 27.1 microM; further addition of Ca2+ (0.2 mM) raised the Ki(app) to 127 microM. For the modification of NADPH inhibition by ADP, S0.5 for Ca2+ was approximately 48 microM. This compares to the Km for Ca2+ of 0.3-1 microM for the activation of the enzyme without NADPH [Denton, R. M., Richards, D. A., & Chin, J. G. (1978) Biochem. J. 176, 899-906; Aogaichi, T., Evans, J., Gabriel, J., & Plaut, G. W. E. (1980) Arch. Biochem. Biophys. 204, 350-360]. ADP did not affect the Ki for NADH. Magnesium citrate, which was about 100-fold more effective as a positive modifier of the enzyme with ADP than without ADP [Gabriel, J. L., & Plaut, G. W. E. (1983) Fed. Proc., Fed. Am. Soc. Exp. Biol. 42, 2082], reversed competitively the inhibition by NADPH in the presence of ADP, but not without ADP. Magnesium citrate did not reverse NADH inhibition.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6466615     DOI: 10.1021/bi00307a037

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

Review 1.  Barth Syndrome: Connecting Cardiolipin to Cardiomyopathy.

Authors:  Nikita Ikon; Robert O Ryan
Journal:  Lipids       Date:  2017-01-09       Impact factor: 1.880

Review 2.  Metabolic biology of 3-methylglutaconic acid-uria: a new perspective.

Authors:  Betty Su; Robert O Ryan
Journal:  J Inherit Metab Dis       Date:  2014-01-10       Impact factor: 4.982

Review 3.  Diversion of Acetyl CoA to 3-Methylglutaconic Acid Caused by Discrete Inborn Errors of Metabolism.

Authors:  Dylan E Jones; Elizabeth A Jennings; Robert O Ryan
Journal:  Metabolites       Date:  2022-04-21

4.  NAD-specific isocitrate dehydrogenase from bovine heart. Interaction with Ca2+ chelators.

Authors:  J L Gabriel; G W Plaut
Journal:  Biochem J       Date:  1985-08-01       Impact factor: 3.857

Review 5.  Mitochondrial Ca2+ concentrations in live cells: quantification methods and discrepancies.

Authors:  Celia Fernandez-Sanz; Sergio De la Fuente; Shey-Shing Sheu
Journal:  FEBS Lett       Date:  2019-05-18       Impact factor: 4.124

6.  Detailed kinetics and regulation of mammalian NAD-linked isocitrate dehydrogenase.

Authors:  Feng Qi; Xuewen Chen; Daniel A Beard
Journal:  Biochim Biophys Acta       Date:  2008-07-11

7.  Regulation of NAD+-linked isocitrate dehydrogenase and 2-oxoglutarate dehydrogenase by Ca2+ ions within toluene-permeabilized rat heart mitochondria. Interactions with regulation by adenine nucleotides and NADH/NAD+ ratios.

Authors:  G A Rutter; R M Denton
Journal:  Biochem J       Date:  1988-05-15       Impact factor: 3.857

8.  NAD(+)-linked isocitrate dehydrogenase in fish tissues.

Authors:  K B Storey; J H Fields
Journal:  Fish Physiol Biochem       Date:  1988-03       Impact factor: 2.794

Review 9.  Regulation of ATP production by mitochondrial Ca(2+).

Authors:  Andrei I Tarasov; Elinor J Griffiths; Guy A Rutter
Journal:  Cell Calcium       Date:  2012-04-12       Impact factor: 6.817

10.  Mitochondrial Calcium Uniporter Affects Neutrophil Bactericidal Activity during Staphylococcus aureus Infection.

Authors:  Andrew J Monteith; Jeanette M Miller; William N Beavers; K Nichole Maloney; Erin L Seifert; Gyorgy Hajnoczky; Eric P Skaar
Journal:  Infect Immun       Date:  2021-12-06       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.